Ally Bridge Group (Ny) LLC Castle Biosciences Inc Transaction History

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$50.07 - $76.78 $5.01 Million - $7.68 Million
-100,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$58.92 - $97.33 $6.48 Million - $10.7 Million
-110,000 Reduced 52.38%
100,000 $6.85 Million
Q4 2020

Feb 16, 2021
BUY
$43.6 - $73.05 $9.16 Million - $15.3 Million
210,000 New
210,000 $14.1 Million

Others Institutions Holding CSTL

# of Institutions
201
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $729M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email